A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic Medications (GRATITUDE II)
Clinical trial NCT04524403 · COMPLETED
Trial details
- NCT number
- NCT04524403
- Sponsor
- Corcept Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-09
- Primary completion
- 2022-07-29
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.